{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:36:00Z","timestamp":1790789760248,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Front. Med."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11684-021-0877-y","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T17:53:02Z","timestamp":1634752382000},"page":"442-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"16","author":[{"given":"Mengping","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caicike","family":"Bayin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Chuffart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Bourova-Flin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Rousseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadi","family":"Khochbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Qing","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"issue":"10","key":"877_CR1","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.6004\/jnccn.2015.0153","volume":"13","author":"JC Alvarnas","year":"2015","unstructured":"Alvarnas JC, Brown PA, Aoun P, Ballen KK, Barta SK, Borate U, Boyer MW, Burke PW, Cassaday R, Castro JE, Coccia PF, Coutre SE, Damon LE, DeAngelo DJ, Douer D, Frankfurt O, Greer JP, Johnson RA, Kantarjian HM, Klisovic RB, Kupfer G, Litzow M, Liu A, Rao AV, Shah B, Uy GL, Wang ES, Zelenetz AD, Gregory K, Smith C. Acute Lymphoblastic Leukemia, Version 2.2015. J Natl Compr Canc Netw 2015; 13(10): 1240\u20131279","journal-title":"J Natl Compr Canc Netw"},{"issue":"16","key":"877_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med 2015; 373(16): 1541\u20131552","journal-title":"N Engl J Med"},{"issue":"2","key":"877_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/CBM-190967","volume":"27","author":"S Aref","year":"2020","unstructured":"Aref S, El Agdar M, Salama O, Zeid TA, Sabry M. Significance of NOTCH1 mutations d\u00e9tections in T-acute lymphoblastic leukemia patients. Cancer Biomark 2020; 27(2): 157\u2013162","journal-title":"Cancer Biomark"},{"issue":"5","key":"877_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1080\/10428194.2018.1522442","volume":"60","author":"GS Guru Murthy","year":"2019","unstructured":"Guru Murthy GS, Pondaiah SK, Abedin S, Atallah E. Incidence and survival of T-cell acute lymphoblastic leukemia in the United States. Leuk Lymphoma 2019; 60(5): 1171\u20131178","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"877_CR5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/10428194.2017.1354372","volume":"59","author":"I Aldoss","year":"2018","unstructured":"Aldoss I, Stein AS. Advances in adult acute lymphoblastic leukemia therapy. Leuk Lymphoma 2018; 59(5): 1033\u20131050","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"877_CR6","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1182\/blood-2006-11-056754","volume":"109","author":"DJ DeAngelo","year":"2007","unstructured":"DeAngelo DJ, Yu D, Johnson JL, Coutre SE, Stone RM, Stopeck AT, Gockerman JP, Mitchell BS, Appelbaum FR, Larson RA. Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. Blood 2007; 109(12): 5136\u20135142","journal-title":"Blood"},{"issue":"2","key":"877_CR7","doi-asserted-by":"publisher","first-page":"e002026","DOI":"10.1136\/jitc-2020-002026","volume":"9","author":"D Caracciolo","year":"2021","unstructured":"Caracciolo D, Riillo C, Ballerini A, Gaipa G, Lhermitte L, Rossi M, Botta C, Duroyon E, Grillone K, Gallo Cantafio ME, Buracchi C, Alampi G, Gulino A, Belmonte B, Conforti F, Golino G, Juli G, Altomare E, Poler\u00e0 N, Scionti F, Arbitrio M, Iannone M, Martino M, Correale P, Talarico G, Ghelli Luserna di Ror\u00e0 A, Ferrari A, Concolino D, Sestito S, Pensabene L, Giordano A, Hildinger M, Di Martino MT, Martinelli G, Tripodo C, Asnafi V, Biondi A, Tagliaferri P, Tassone P. Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lympho-blastic leukemia. J Immunother Cancer 2021; 9(2): e002026","journal-title":"J Immunother Cancer"},{"issue":"3","key":"877_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","volume":"144","author":"MJ You","year":"2015","unstructured":"You MJ, Medeiros LJ, Hsi ED. T-lymphoblastic leukemia\/lymphoma. Am J Clin Pathol 2015; 144(3): 411\u2013422","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"877_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","volume":"129","author":"T Girardi","year":"2017","unstructured":"Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood 2017; 129(9): 1113\u20131123","journal-title":"Blood"},{"issue":"8","key":"877_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, McCastlain K, Edmonson M, Pounds SB, Shi L, Zhou X, Ma X, Sioson E, Li Y, Rusch M, Gupta P, Pei D, Cheng C, Smith MA, Auvil JG, Gerhard DS, Relling MV, Winick NJ, Carroll AJ, Heerema NA, Raetz E, Devidas M, Willman CL, Harvey RC, Carroll WL, Dunsmore KP, Winter SS, Wood BL, Sorrentino BP, Downing JR, Loh ML, Hunger SP, Zhang J, Mullighan CG. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet 2017; 49(8): 1211\u20131218","journal-title":"Nat Genet"},{"issue":"2","key":"877_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1073\/pnas.1717125115","volume":"115","author":"B Chen","year":"2018","unstructured":"Chen B, Jiang L, Zhong ML, Li JF, Li BS, Peng LJ, Dai YT, Cui BW, Yan TQ, Zhang WN, Weng XQ, Xie YY, Lu J, Ren RB, Chen SN, Hu JD, Wu DP, Chen Z, Tang JY, Huang JY, Mi JQ, Chen SJ. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2018; 115(2): 373\u2013378","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"877_CR12","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00277-015-2474-0","volume":"94","author":"L Yuan","year":"2015","unstructured":"Yuan L, Lu L, Yang Y, Sun H, Chen X, Huang Y, Wang X, Zou L, Bao L. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival. Ann Hematol 2015; 94(11): 1817\u20131828","journal-title":"Ann Hematol"},{"issue":"24","key":"877_CR13","doi-asserted-by":"publisher","first-page":"6731","DOI":"10.1073\/pnas.1601537113","volume":"113","author":"CH Yeh","year":"2016","unstructured":"Yeh CH, Bellon M, Pancewicz-Wojtkiewicz J, Nicot C. Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients. Proc Natl Acad Sci USA 2016; 113(24): 6731\u20136736","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"877_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11899-018-0455-9","volume":"13","author":"M Hefazi","year":"2018","unstructured":"Hefazi M, Litzow MR. Recent advances in the biology and treatment of T cell acute lymphoblastic leukemia. Curr Hematol Malig Rep 2018; 13(4): 265\u2013274","journal-title":"Curr Hematol Malig Rep"},{"key":"877_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-3-319-89512-3_18","volume":"1066","author":"AC McCarter","year":"2018","unstructured":"McCarter AC, Wang Q, Chiang M. Notch in leukemia. Adv Exp Med Biol 2018; 1066: 355\u2013394","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"877_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2013.09.005","volume":"141","author":"N Takebe","year":"2014","unstructured":"Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther 2014; 141(2): 140\u2013149","journal-title":"Pharmacol Ther"},{"key":"877_CR17","doi-asserted-by":"publisher","unstructured":"Kaushik B, Pal D, Saha S. Gamma secretase inhibitor: therapeutic target via NOTCH signaling in T cell acute lymphoblastic leukemia. Curr Drug Targets 2021; [Epub ahead of print] doi: https:\/\/doi.org\/10.2174\/1389450122666210203192752","DOI":"10.2174\/1389450122666210203192752"},{"issue":"48","key":"877_CR18","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.0606108103","volume":"103","author":"T Palomero","year":"2006","unstructured":"Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, Barnes KC, O\u2019Neil J, Neuberg D, Weng AP, Aster JC, Sigaux F, Soulier J, Look AT, Young RA, Califano A, Ferrando AA. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006; 103(48): 18261\u201318266","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"877_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1073\/pnas.0806445106","volume":"106","author":"AA Margolin","year":"2009","unstructured":"Margolin AA, Palomero T, Sumazin P, Califano A, Ferrando AA, Stolovitzky G. ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes. Proc Natl Acad Sci USA 2009; 106(1): 244\u2013249","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"877_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ccell.2020.01.001","volume":"37","author":"J Jiang","year":"2020","unstructured":"Jiang J, Wang J, Yue M, Cai X, Wang T, Wu C, Su H, Wang Y, Han M, Zhang Y, Zhu X, Jiang P, Li P, Sun Y, Xiao W, Feng H, Qing G, Liu H. Direct phosphorylation and stabilization of MYC by Aurora B kinase promote T-cell leukemogenesis. Cancer Cell 2020; 37(2): 200\u2013215.e5","journal-title":"Cancer Cell"},{"issue":"9","key":"877_CR21","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","volume":"129","author":"M Sanchez-Martin","year":"2017","unstructured":"Sanchez-Martin M, Ferrando A. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. Blood 2017; 129(9): 1124\u20131133","journal-title":"Blood"},{"issue":"18","key":"877_CR22","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1182\/blood-2016-01-692855","volume":"128","author":"MY Chiang","year":"2016","unstructured":"Chiang MY, Wang Q, Gormley AC, Stein SJ, Xu L, Shestova O, Aster JC, Pear WS. High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia. Blood 2016; 128(18): 2229\u20132240","journal-title":"Blood"},{"issue":"10","key":"877_CR23","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.18632\/oncotarget.1873","volume":"5","author":"M Loosveld","year":"2014","unstructured":"Loosveld M, Castellano R, Gon S, Goubard A, Crouzet T, Pouyet L, Prebet T, Vey N, Nadel B, Collette Y, Payet-Bornet D. Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL. Oncotarget 2014; 5(10): 3168\u20133172","journal-title":"Oncotarget"},{"issue":"10","key":"877_CR24","doi-asserted-by":"publisher","first-page":"a014266","DOI":"10.1101\/cshperspect.a014266","volume":"4","author":"MR McKeown","year":"2014","unstructured":"McKeown MR, Bradner JE. Therapeutic strategies to inhibit MYC. Cold Spring Harb Perspect Med 2014; 4(10): a014266","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"877_CR25","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/cancers11101436","volume":"11","author":"M Beyer","year":"2019","unstructured":"Beyer M, Romanski A, Mustafa AM, Pons M, B\u00fcchler I, Vogel A, Pautz A, Sellmer A, Schneider G, Bug G, Kr\u00e4mer OH. HDAC3 activity is essential for human leukemic cell growth and the expression of \u03b1-catenin, MYC, and WT1. Cancers (Basel) 2019; 11 (10): 1436","journal-title":"Cancers (Basel)"},{"issue":"2","key":"877_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1158\/1535-7163.MCT-16-0390","volume":"16","author":"K Sun","year":"2017","unstructured":"Sun K, Atoyan R, Borek MA, Dellarocca S, Samson ME, Ma AW, Xu GX, Patterson T, Tuck DP, Viner JL, Fattaey A, Wang J. Dual HDAC and PI3K inhibitor CUDC-907 downregulates MYC and suppresses growth of MYC-dependent cancers. Mol Cancer Ther 2017; 16(2): 285\u2013299","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"877_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/leu.2017.282","volume":"32","author":"M Waibel","year":"2018","unstructured":"Waibel M, Vervoort SJ, Kong IY, Heinzel S, Ramsbottom KM, Martin BP, Hawkins ED, Johnstone RW. Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia. Leukemia 2018; 32(1): 237\u2013241","journal-title":"Leukemia"},{"issue":"7","key":"877_CR28","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1093\/nar\/gkaa088","volume":"48","author":"F Ferrante","year":"2020","unstructured":"Ferrante F, Giaimo BD, Bartkuhn M, Zimmermann T, Close V, Mertens D, Nist A, Stiewe T, Meier-Soelch J, Kracht M, Just S, Kl\u00f6ble P, Oswald F, Borggrefe T. HDAC3 functions as a positive regulator in Notch signal transduction. Nucleic Acids Res 2020; 48(7): 3496\u20133512","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"877_CR29","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1038\/emboj.2010.176","volume":"29","author":"N Reynoird","year":"2010","unstructured":"Reynoird N, Schwartz BE, Delvecchio M, Sadoul K, Meyers D, Mukherjee C, Caron C, Kimura H, Rousseaux S, Cole PA, Panne D, French CA, Khochbin S. Oncogenesis by sequestration of CBP\/p300 in transcriptionally inactive hyperacetylated chromatin domains. EMBO J 2010; 29(17): 2943\u20132952","journal-title":"EMBO J"},{"issue":"6","key":"877_CR30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011; 146(6): 904\u2013917","journal-title":"Cell"},{"issue":"1","key":"877_CR31","doi-asserted-by":"publisher","first-page":"e3807","DOI":"10.1002\/bmc.3807","volume":"31","author":"PS Suresh","year":"2017","unstructured":"Suresh PS, Devaraj VC, Srinivas NR, Mullangi R. Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine. Biomed Chromatogr 2017; 31(1): e3807","journal-title":"Biomed Chromatogr"},{"key":"877_CR32","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.biopha.2016.08.023","volume":"83","author":"Z Liu","year":"2016","unstructured":"Liu Z, Ding K, Li L, Liu H, Wang Y, Liu C, Fu R. A novel histone deacetylase inhibitor chidamide induces G0\/G1 arrest and apoptosis in myelodysplastic syndromes. Biomed Pharmacother 2016; 83: 1032\u20131037","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"877_CR33","first-page":"3169","volume":"8","author":"S Zhao","year":"2016","unstructured":"Zhao S, Guo J, Zhao Y, Fei C, Zheng Q, Li X, Chang C. Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2\/STAT3 signaling. Am J Transl Res 2016; 8(7): 3169\u20133178","journal-title":"Am J Transl Res"},{"issue":"44","key":"877_CR34","doi-asserted-by":"publisher","first-page":"77586","DOI":"10.18632\/oncotarget.20659","volume":"8","author":"T Jiang","year":"2017","unstructured":"Jiang T, Wang F, Hu L, Cheng X, Zheng Y, Liu T, Jia Y. Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4. Oncotarget 2017; 8(44): 77586\u201377594","journal-title":"Oncotarget"},{"issue":"8","key":"877_CR35","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3324\/haematol.2017.181172","volume":"103","author":"J He","year":"2018","unstructured":"He J, Chen Q, Gu H, Chen J, Zhang E, Guo X, Huang X, Yan H, He D, Yang Y, Zhao Y, Wang G, He H, Yi Q, Cai Z. Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease. Haematologica 2018; 103(8): 1369\u20131379","journal-title":"Haematologica"},{"issue":"4","key":"877_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10637-017-0552-y","volume":"36","author":"J Zhou","year":"2018","unstructured":"Zhou J, Zhang C, Sui X, Cao S, Tang F, Sun S, Wang S, Chen B. Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK\/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway. Invest New Drugs 2018; 36(4): 571 -580","journal-title":"Invest New Drugs"},{"issue":"1","key":"877_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13045-017-0439-6","volume":"10","author":"Y Shi","year":"2017","unstructured":"Shi Y, Jia B, Xu W, Li W, Liu T, Liu P, Zhao W, Zhang H, Sun X, Yang H, Zhang X, Jin J, Jin Z, Li Z, Qiu L, Dong M, Huang X, Luo Y, Wang X, Wang X, Wu J, Xu J, Yi P, Zhou J, He H, Liu L, Shen J, Tang X, Wang J, Yang J, Zeng Q, Zhang Z, Cai Z, Chen X, Ding K, Hou M, Huang H, Li X, Liang R, Liu Q, Song Y, Su H, Gao Y, Liu L, Luo J, Su L, Sun Z, Tan H, Wang H, Wang J, Wang S, Zhang H, Zhang X, Zhou D, Bai O, Wu G, Zhang L, Zhang Y. Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China. J Hematol Oncol 2017; 10(1): 69","journal-title":"J Hematol Oncol"},{"issue":"3","key":"877_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5582\/irdr.2016.01024","volume":"5","author":"X Lu","year":"2016","unstructured":"Lu X, Ning Z, Li Z, Cao H, Wang X. Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China. Intractable Rare Dis Res 2016; 5(3): 185\u2013191","journal-title":"Intractable Rare Dis Res"},{"issue":"4","key":"877_CR39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/10428194.2019.1691195","volume":"61","author":"W Guan","year":"2020","unstructured":"Guan W, Jing Y, Dou L, Wang M, Xiao Y, Yu L. Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma\/leukemia. Leuk Lymphoma 2020; 61(4): 855\u2013861","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"877_CR40","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1038\/bcj.2013.31","volume":"3","author":"XQ Weng","year":"2013","unstructured":"Weng XQ, Shen Y, Sheng Y, Chen B, Wang JH, Li JM, Mi JQ, Chen QS, Zhu YM, Jiang CL, Yan H, Zhang XX, Huang T, Zhu Z, Chen Z, Chen SJ. Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia. Blood Cancer J 2013; 3(8): e133","journal-title":"Blood Cancer J"},{"issue":"10","key":"877_CR41","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1158\/1078-0432.CCR-05-2832","volume":"12","author":"YM Zhu","year":"2006","unstructured":"Zhu YM, Zhao WL, Fu JF, Shi JY, Pan Q, Hu J, Gao XD, Chen B, Li JM, Xiong SM, Gu LJ, Tang JY, Liang H, Jiang H, Xue YQ, Shen ZX, Chen Z, Chen SJ. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clin Cancer Res 2006; 12(10): 3043\u20133049","journal-title":"Clin Cancer Res"},{"issue":"1","key":"877_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013; 29(1): 15\u201321","journal-title":"Bioinformatics"},{"issue":"2","key":"877_CR43","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics 2015; 31(2): 166\u2013169","journal-title":"Bioinformatics"},{"issue":"6","key":"877_CR44","doi-asserted-by":"publisher","first-page":"e0157022","DOI":"10.1371\/journal.pone.0157022","volume":"11","author":"H Varet","year":"2016","unstructured":"Varet H, Brillet-Gu\u00e9guen L, Copp\u00e9e JY, Dillies MA. SARTools: a DESeq2- and EdgeR-based R pipeline for comprehensive differential analysis of RNA-Seq data. PLoS One 2016; 11(6): e0157022","journal-title":"PLoS One"},{"issue":"2","key":"877_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3892\/ijmm.2017.2849","volume":"39","author":"JJ Xu","year":"2017","unstructured":"Xu JJ, Yao FR, Jiang M, Zhang YT, Guo F. High-resolution melting analysis for rapid and sensitive NOTCH1 screening in chronic lymphocytic leukemia. Int J Mol Med 2017; 39(2): 415\u2013422","journal-title":"Int J Mol Med"},{"issue":"11","key":"877_CR46","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1080\/10428194.2017.1300896","volume":"58","author":"B Squiban","year":"2017","unstructured":"Squiban B, Ahmed ST, Frazer JK. Creation of a human T-ALL cell line online database. Leuk Lymphoma 2017; 58(11): 2728\u20132730","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"877_CR47","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1182\/blood-2007-12-130096","volume":"112","author":"ML Sulis","year":"2008","unstructured":"Sulis ML, Williams O, Palomero T, Tosello V, Pallikuppam S, Real PJ, Barnes K, Zuurbier L, Meijerink JP, Ferrando AA. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. Blood 2008; 112(3): 733\u2013740","journal-title":"Blood"},{"issue":"6","key":"877_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/cells7060058","volume":"7","author":"L Horvat","year":"2018","unstructured":"Horvat L, Antica M, Matuli\u0107 M. Effect of Notch and PARP pathways\u2019 inhibition in leukemic cells. Cells 2018; 7(6): 58","journal-title":"Cells"},{"issue":"5","key":"877_CR49","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1073\/pnas.0307708100","volume":"101","author":"CY Gui","year":"2004","unstructured":"Gui CY, Ngo L, Xu WS, Richon VM, Marks PA. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci USA 2004; 101(5): 1241\u20131246","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"877_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/ars.2014.5915","volume":"23","author":"KR Stengel","year":"2015","unstructured":"Stengel KR, Hiebert SW. Class I HDACs affect DNA replication, repair, and chromatin structure: implications for cancer therapy. Antioxid Redox Signal 2015; 23(1): 51\u201365","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"877_CR51","first-page":"190","volume":"48","author":"J Boulaire","year":"2000","unstructured":"Boulaire J, Fotedar A, Fotedar R. The functions of the cdk-cyclin kinase inhibitor p21WAF1. Pathol Biol (Paris) 2000; 48(3): 190\u2013202","journal-title":"Pathol Biol (Paris)"},{"issue":"3","key":"877_CR52","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni1045","volume":"5","author":"F Radtke","year":"2004","unstructured":"Radtke F, Wilson A, Mancini SJ, MacDonald HR. Notch regulation of lymphocyte development and function. Nat Immunol 2004; 5(3): 247\u2013253","journal-title":"Nat Immunol"},{"issue":"1","key":"877_CR53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nri1998","volume":"7","author":"BA Osborne","year":"2007","unstructured":"Osborne BA, Minter LM. Notch signalling during peripheral T-cell activation and differentiation. Nat Rev Immunol 2007; 7(1): 64\u201375","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"877_CR54","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1084\/jem.20141843","volume":"212","author":"VW Yu","year":"2015","unstructured":"Yu VW, Saez B, Cook C, Lotinun S, Pardo-Saganta A, Wang YH, Lymperi S, Ferraro F, Raaijmakers MH, Wu JY, Zhou L, Rajagopal J, Kronenberg HM, Baron R, Scadden DT. Specific bone cells produce DLL4 to generate thymus-seeding progenitors from bone marrow. J Exp Med 2015; 212(5): 759\u2013774","journal-title":"J Exp Med"},{"issue":"10230","key":"877_CR55","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet 2020; 395(10230): 1146\u20131162","journal-title":"Lancet"},{"issue":"6","key":"877_CR56","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/s41375-018-0127-8","volume":"32","author":"J De Bie","year":"2018","unstructured":"De Bie J, Demeyer S, Alberti-Servera L, Geerdens E, Segers H, Broux M, De Keersmaecker K, Michaux L, Vandenberghe P, Voet T, Boeckx N, Uyttebroeck A, Cools J. Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia. Leukemia 2018; 32(6): 1358\u20131369","journal-title":"Leukemia"},{"issue":"1","key":"877_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1084\/jem.20151778","volume":"215","author":"G Roti","year":"2018","unstructured":"Roti G, Qi J, Kitara S, Sanchez-Martin M, Saur Conway A, Varca AC, Su A, Wu L, Kung AL, Ferrando AA, Bradner JE, Stegmaier K. Leukemia-specific delivery of mutant NOTCH1 targeted therapy. J Exp Med 2018; 215(1): 197\u2013216","journal-title":"J Exp Med"},{"issue":"10","key":"877_CR58","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/nm.3665","volume":"20","author":"D Herranz","year":"2014","unstructured":"Herranz D, Ambesi-Impiombato A, Palomero T, Schnell SA, Belver L, Wendorff AA, Xu L, Castillo-Martin M, Llobet-Nav\u00e1s D, Cordon-Cardo C, Clappier E, Soulier J, Ferrando AAA. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med 2014; 20(10): 1130\u20131137","journal-title":"Nat Med"},{"issue":"2","key":"877_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4161\/15384101.2014.989129","volume":"14","author":"D Herranz","year":"2015","unstructured":"Herranz D, Ferrando AA. An oncogenic enhancer enemy (N-Me) in T-ALL. Cell Cycle 2015; 14(2): 167\u2013168","journal-title":"Cell Cycle"},{"issue":"6","key":"877_CR60","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/15592294.2015.1034416","volume":"10","author":"D Sengupta","year":"2015","unstructured":"Sengupta D, Kannan A, Kern M, Moreno MA, Vural E, Stack B Jr, Suen JY, Tackett AJ, Gao L. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma. Epigenetics 2015; 10(6): 460\u2013466","journal-title":"Epigenetics"},{"issue":"2","key":"877_CR61","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013; 153(2): 320\u2013334","journal-title":"Cell"},{"issue":"1","key":"877_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.stem.2013.06.008","volume":"13","author":"D Levens","year":"2013","unstructured":"Levens D, Aplan PD. Notching up MYC gives a LIC. Cell Stem Cell 2013; 13(1): 8\u20139","journal-title":"Cell Stem Cell"},{"issue":"5","key":"877_CR63","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.cell.2019.07.048","volume":"178","author":"CW Cheng","year":"2019","unstructured":"Cheng CW, Biton M, Haber AL, Gunduz N, Eng G, Gaynor LT, Tripathi S, Calibasi-Kocal G, Rickelt S, Butty VL, Moreno-Serrano M, Iqbal AM, Bauer-Rowe KE, Imada S, Ulutas MS, Mylonas C, Whary MT, Levine SS, Basbinar Y, Hynes RO, Mino-Kenudson M, Deshpande V, Boyer LA, Fox JG, Terranova C, Rai K, Piwnica-Worms H, Mihaylova MM, Regev A, Yilmaz OH. Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet. Cell 2019; 178(5): 1115\u20131131.e15","journal-title":"Cell"}],"container-title":["Frontiers of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-021-0877-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11684-021-0877-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-021-0877-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T05:15:00Z","timestamp":1658294100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11684-021-0877-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1007\/s11684-021-0877-y","relation":{},"ISSN":["2095-0217","2095-0225"],"issn-type":[{"value":"2095-0217","type":"print"},{"value":"2095-0225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"11 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}